| Academic | Project Title | Status |
|---|---|---|
Prof Minoti Apte & Dr Zhihong Xu SWS Clinical School and Ingham Institute for Applied Medical Research
|
Novel therapeutic approaches for pancreatic cancer – characterising and targeting stromal-tumour interactions | Current. October 2021 |
Prof Minoti Apte & Dr Chamini Perera SWS Clinical School and Ingham Institute for Applied Medical Research
|
Pancreatic-cancer related diabetes | Current. October 2021 |
Dr Chamini Perera South Western Sydney Clinical School
|
Pancreatic Cancer Related Diabetes, Pancreatic Cancer, Pancreatitis |
Current. October 2021 |
Dr Zhihong Xu South Western Sydney Clinical School |
Role of PSCs in progression of pancreatitis; Novel treatments targeting the stroma in pancreatic cancer; Pancreatic cancer-related diabetes
|
Current. October 2021 |
Dr Vikneswary Batumalai vikneswary.batumalai@health.nsw.gov.au South Western Sydney Clinical School
|
Using Big Data to reduce variation in radiotherapy | Current. October 2021 |
A/Prof. Albert S Mellick South Western Sydney Clinical School
|
Towards a diagnostic tool for the early detection of cancer in Butterfly disease |
Current. October 2021 |
| Prince of Wales Clinical School |
Please contact Dr Prashanth J Rao for latest projects available
|
Current. October 2021 |
Dr Yafeng Ma yafeng.ma@unsw.edu.au & A.Prof. Therese Becker Ingham Institute for Applied Medical Research
|
3D cell culture and drug screening using lung pleural fluid for personalized medicine in lung cancer patients |
Current. October 2021 |
A/Prof. Murray Killingsworth Ingham Institute for Applied Medical Research
|
Developing new tests for surgical pathology | Current. October 2021 |
Dr Sean Porazinski Garvan Institute of Medical Research |
Characterising the molecular diversity of pancreatic cancer: Personalised medicine in action
|
Current, October 2021 |
Children's Cancer Institute
|
Inhibiting the MYCN oncogenic signal | Current, October 2021 |
|
Children's Cancer Institute |
Therapeutic and preventative strategies for children with high-risk neuroblastoma: targeting high fat diet-related metabolism
|
Current, October 2021 |
|
Children's Cancer Institute |
Using single cell molecular profiling to identify novel therapeutic targets in paediatric cancers
|
Current, October 2021 |
|
Children's Cancer Institute |
Using synthetic lethality screen to develop novel combination therapies to treat paediatric cancers
|
Current, October 2021 |
Dr Dannielle Upton Children's Cancer Institute |
Developing novel combination therapies for diffuse intrinsic pontine gliomas
|
Current, October 2021 |
Dr Ben Rayner Children's Cancer Institute
|
Development of novel treatment strategies for childhood brain tumours |
Current, October 2021 |
Dr Angelica Merlot Children's Cancer Institute |
Dissecting the role of endoplasmic reticulum stress in cancer cell progression and metastasis
|
Current, October 2021 |
Dr Fatima Valdes Mora Children's Cancer Institute
|
Epigenetic therapy in diffuse intrinsic pontine glioma |
Current, October 2021 |
Dr Orazio Vittorio Children's Cancer Institute |
Investigating immunotherapeutic strategies in DIPG – understanding tumour microenvironment in DIPG
|
Current, October 2021 |
Dr Mukesh Raipuria Children's Cancer Institute
|
Risk factors and their prevention to embryonal cancer |
Current, October 2021 |
Garvan Institute of Medical Research
|
Understanding the role of the extracellular matrix in cancer progression | Current, October 2021 |
Garvan Institute of Medical Research
|
Single-cell modelling of drug response and chemoresistance | Current, October 2021 |
Dr Vikneswary Batumalai, Dr Michael Jameson & Dr Jeremy de Leon St Vincent’s Clinical School, Radiation Oncology
|
Quantitative Imaging Biomarkers Analysis with MR-Linac to predict radiotherapy response |
Current October 2021 |
Dr Vikneswary Batumalai, Dr Michael Jameson & Dr Jeremy de Leon St Vincent’s Clinical School, Radiation Oncology
|
Daily adaptive prostate SBRT using MR-LInac: In silico assessment of delivered doses compared to non-adaptive standard treatment |
Current October 2021 |
Dr Svetlana Cherepanoff svetlana.cherepanoff@svha.org.au St Vincent’s Hospital Sydney |
1. Conjunctival melanoma disease presentations and outcomes 2. Digital archiving and online medical education of ageing and age-related macular degeneration
|
Current October 2021 |
A/Prof Jeff Holst & Dr Kanu Wahi Translational Cancer Metabolism Laboratory, School of Biomedical Sciences & POW Clinical School
|
Novel strategies to starve cancer cells | Current October 2021 |
Prof. Jeff Holst Adult Cancer Program
|
Novel strategies to starve cancer cells |
Current October 2021 |
Dr Ashwin Unnikrishnan ashwin.unnikrishnan@unsw.edu.au Adult Cancer Program
|
Investigating RNA splicing alterations as an unexplored causal factor of leukaemia |
Current October 2021 |
Dr Omid Faridani Adult Cancer Program |
Single-cell multi-omics of circulating tumour cell in pancreatic cancer
|
Current October 2021 |
A/Prof Amany Zekry St George & Sutherland Clinical School |
Understanding role of the microbiome in determining response to immunotherapy in Hepatocellular
|
Current. October 2021 |
Dr Xiao-Tao Jiang & Dr Howard Yim Microbiome Research Centre, St George and Sutherland Clinical School
|
The role of enteric virome in colon cancer | Current. October 2021 |
| Dr Howard Yim & Prof. Emad El-Omar |
Host and Microbiome Interaction along Colorectal Cancer development
|
Current. October 2021 |
Dr MoonSun Jung & Dr Caroline Atkinson Children's Cancer Institute |
Developing mouse models for high-risk neuroblastoma metastasis using bioluminescent patient-derived xenograft (PDX) cells
|
Current. October 2021. |
Dr Alvin Kamili, Dr Caroline Atkinson & Dr Jamie Fletcher Children's Cancer Institute
|
Targeting BCL-2 family proteins in high-risk neuroblastoma |
Current. October 2021. |
|
Children's Cancer Institute |
Characterisation of cancer stem cells in neuroblastoma: A role of telomeres
|
Current. Updated October 2021. |
|
Children's Cancer Institute |
The role and targeting of Anaplastic Lymphoma Kinase (ALK) in neuroblastoma.
|
Current. Updated October 2021. |
Cancer Institute NSW Fellow, School of Biomedical Sciences
|
The role of pathobionts in the development of metaplasia |
Current. Updated October 2021. |
Microbiome Research Centre, St George and Sutherland Clinical School
|
Role of the microbiome in lung cancer and its treatment. | Current. Updated October 2021. |
|
St George & Sutherland Clinical School |
Validation of extracellular vesicle protein and RNA biomarkers in blood and urine for the personalised treatment decision of prostate cancer patients
|
Current. Updated October 2021. |
Dr James Thompson and Dr Kevin Ni St George & Sutherland Clinical School
|
Exosomal biomarkers in bladder cancer diagnosis and surveillance | Current. Updated October 2021. |
|
Children's Cancer Institute |
The critical roles of long noncoding RNAs in tumourigenesis and as targets for cancer therapy
|
Current. October 2021 |
|
Children's Cancer Institute |
Enhancing the anticancer efficacy of transcriptional super-enhancer inhibitors
|
Current October 2021 |
|
Children's Cancer Institute |
Genome-wide analysis of novel long noncoding RNAs critical for tumorigenesis
|
Current October 2021 |
Prof Richard Lock & Dr Cara Toscan Children’s Cancer Institute |
Mechanisms of AKR1C3 gene expression in paediatric acute lymphoblastic leukaemia with respect to sensitivity to the AKR1C3-activated prodrug OBI-3424
|
Current October 2021 |
Dr Angelica Merlot & Prof Maria Kavallaris Children's Cancer Institute |
Dissecting the role of endoplasmic reticulum stress in cancer cell progression and metastasis in the tumour microenvironment
|
Current. October 2021. |
|
Single Molecule Science, School of Biomedical Sciences |
A cellular sense of touch: how do cancer cells use force sensing molecules to invade and migrate
|
Current. October 2021 |
|
Single Molecular Science, School of Biomedical Sciences |
Live imaging of killer immune cell behaviour around a solid tumour mass
|
Current. October 2021 |
Prof. Nigel Turner School of Biomedical Sciences |
Targeting cellular energy metabolism to treat pancreatic cancer
|
Current. October 2021 |
Dr Vaishnavi Ananthanarayanan School of Biomedical Sciences
|
Cellular decision making during cancer |
Current. October 2021 |
Dr John Lock School of Biomedical Sciences |
Mapping cancer cell signalling through single-cell quantitative imaging and machine learning
|
Current. October 2021 |
Prof. Levon Khachigian School of Biomedical Sciences
|
Development of novel cancer pharmacotherapeutics |
Current. October 2021 |
|
Adult Cancer Program & School of Biomedical Sciences |
Pre-clinical evaluation of a dual kinase inhibitor to overcome chemotherapy resistance in leukemic cells
|
Current. October 2021 |
|
Adult Cancer Program & School of Biomedical Sciences |
Validation of novel drug targets identified by CRISPR/Cas9 in myeloid leukaemia cells
|
Current. October 2021 |
Dr Liang Joo Leow & Natalie Teh 69 Burton St Darlinghurst |
Comparison of basal cell carcinoma clearance rates between oral sonidegib, surgery and radiotherapy
|
Current. October 2021 |
Prof John Whitelock & Dr Kang Liang Graduate School of Biomedical Engineering Chemical & Engineering
|
The development of an in vitro vascular system to test a novel diagnostic for circulating tumour cells.
|
Current. Updated October 2021 |